Abstract: A compound having the formula Ir(LA)n(LB)3-n is disclosed wherein LA is an aza-DBF ligand and LB is an alkyl-substituted phenylpyridine ligand, wherein the compound has a structure according to Formula I: wherein A1, A2, A3, A4, A5, A6, A7, and A8 comprise carbon or nitrogen; wherein at least one of A1, A2, A3, A4, A5, A6, A7, and A8 is nitrogen; wherein ring B is bonded to ring A through a C—C bond; wherein the iridium is bonded to ring A through a Ir—C bond; wherein X is O, S, or Se; wherein R1 and R2 each independently represent mono-, di-, tri-, tetra-substitution, or no substitution; wherein R? and R? each independently represent mono-, di-substitution, or no substitution; wherein any adjacent substitutions in R?, R?, R1, R2, R3, R4, R5, and R6 are optionally linked together to form a ring; wherein R1, R2, R?, and R? are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl,

Abstract: A composition including a first compound capable of functioning as a phosphorescent emitter in an OLED is provided. The first compound has at least one aromatic ring and at least one substituent R directly bonded to one of the at least one aromatic rings. Each substituent R has the formula of where (a) G1 is selected from NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; and G2 is a non-aromatic polycyclic group; (b) G1 is a direct bond; and G2 is a non-aromatic spiro polycyclic group; or (c) G1 is selected from direct bond, NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; G2 is a non-aromatic polycyclic group; and R is directly bonded to a phenyl, pyridine, or triazine. R1, R2, and R3 are a variety of substituents. Formulations and devices, such as an OLEDs, that include the first compound are also described.

Abstract: The present disclosure relates to novel iridium complexes that can be used in organic light emitting devices (OLEDs). The present disclosure also relates to devices and formulations that incorporate the iridium complexes.

Abstract: A compound having a Pt tetradentate structure of Formula 1, is provided. In the structure of Formula 1, rings C and D each independently represent 5- or 6-membered carbocyclic or heterocyclic ring; L1, L2, and L3 are each independently a direct bond, BR, NR, PR, O, S, Se, C?O, S?O, SO2, SiRR?, GeRR?, alkyl, cycloalkyl, or a combination thereof; the sum of n1 and n2 is 1 or 2; X is selected from NRE, O, S, and Se; X3 and X4 each independently carbon or nitrogen; and one of Q1, Q3, and Q4 is oxygen, and the remaining two of Q1, Q3, and Q4 each represents a direct bond. Formulations and devices, such as an OLEDs, that include the compound of Formula 1 are also described.

Abstract: Organometallic compounds comprising an imidazole carbene ligand having a N-containing ring fused to the imidazole ring are provided. In particular, the N-containing ring fused to the imidazole ring may contain one nitrogen atom or more than one nitrogen atom. These compounds may demonstrate high photoluminescent (PL) efficiency, Gaussian emission spectra, and/or short excited state lifetimes. These materials may be especially useful as blue phosphorescent emitters.

Abstract: A compound that includes a ligand L, having the formula, is provided. In the structure of Formula I, each R1, R2, R3, R4, R4, R5, R6, R7, and R8 is independently selected from a variety of substituents; any adjacent substituents are optionally joined or fused into a ring; at least one of R3, R4, and R5 is not hydrogen; “a” is an integer from 0 to 10; (i) when a is 0, at least one of R7, R8, and an R2 adjacent to ring B, is not hydrogen, and (ii) when a is 1 to 10, at least one of an R2 adjacent to ring A and an R6 adjacent to ring C is not hydrogen; ligand L is coordinated to a metal M having an atomic weight greater than 40; and ligand L is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand.

Abstract: A compound having the formula [LA]yIr[LB]x is disclosed, where LA is selected from one of the following:

Abstract: A compound having a Pt tetradentate structure selected from the group consisting of is provided. In the structures of Formula 1 and Formula 2, rings C and D each independently represent 5- or 6-membered carbocyclic or heterocyclic ring; L1, L2, and L3 are each independently a direct bond, BR, NR, PR, O, S, Se, C?O, S?O, SO2, SiRR?, GeRR?, alkyl, cycloalkyl, or a combination thereof; the sum of n1 and n2 is 1 or 2; X is selected from NRE, O, S, and Se; X3 and X4 each independently carbon or nitrogen; and one of Q1, Q3, and Q4 is oxygen, and the remaining two of Q1, Q3, and Q4 each represents a direct bond. Formulations and devices, such as an OLEDs, that include the compound of Formulas 1 and 2 are also described.

Abstract: A compound having a first ligand LA having the Formula: Formula I is disclosed, wherein rings A is a 5- or 6-membered carbocyclic or heterocyclic ring; wherein RA and RB each independently represent mono to the possible maximum number of substitution, or no substitution; wherein Z1 is carbon or nitrogen; wherein each RA and RB is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two substituents are optionally joined or fused into a ring; wherein X1 to X4 each independently represent a carbon or nitrogen; wherein at least one of X1 to X4 is nitrogen; wherein the ligand LA is coordinated to a metal M; wherein the metal M can be coordinated to other ligands; and wherein the ligand LA is optionally l

Abstract: A compound having the formula: Formula I is disclosed. The compound is useful as emitters in OLEDs.

Abstract: A compound having the formula Ir(LA)n(LB)3?n is disclosed wherein LA is an aza-DBF ligand and LB is an alkyl-substituted phenylpyridine ligand, wherein the compound has a structure according to Formula I: wherein A1, A2, A3, A4, A5, A6, A7, and A8 comprise carbon or nitrogen; wherein at least one of A1, A2, A3, A4, A5, A6, A7, and A8 is nitrogen; wherein ring B is bonded to ring A through a C—C bond; wherein the iridium is bonded to ring A through a Ir—C bond; wherein X is O, S, or Se; wherein R1 and R2 each independently represent mono-, di-, tri-, tetra-substitution, or no substitution; wherein R? and R? each independently represent mono-, di-substitution, or no substitution; wherein any adjacent substitutions in R?, R?, R1, R2, R3, R4, R5, and R6 are optionally linked together to form a ring; wherein R1, R2, R?, and R?are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl,

Abstract: A compound having a structure according Formula Ir(LA)n(LB)3?n: is described. In the structure of Formula Ir(LA)n(LB)3?n: A1, A2, A3, A4, A5, A6, A7, and A8 are each carbon or nitrogen; at least one of A1, A2, A3, A4, A5, A6, A7, and A8 is nitrogen; ring B is bonded to ring A through a C—C bond; the iridium is bonded to ring A through an Ir—C bond; X is O, S, or Se; R1, R2, R3, and R4 each independently represent no substitutions up to the maximum possible substitutions; any adjacent substitutions in R1, R2, R3, and R4 are optionally linked together to form a ring; each R1, R2, R3, R4, and R5 is independently selected from a variety of substituents; and n is an integer from 1 to 2. Formulations and devices, such as an OLEDs, that include the compound of Formula Ir(LA)n(LB)3?n are also described.

Abstract: Imidazo[1,2-f]phenanthridine compounds are provided. The compounds have a twisted aryl moiety further substituted by alkyl having four or more atoms. The compounds may be used in organic light emitting devices, particularly as emissive dopants, providing devices with improved efficiency, stability, and manufacturing. In particular, the compounds provided herein may be used in blue devices having high efficiency.

Abstract: Metal complexes with cyclic ligands having Formula (I), are disclosed. Ligands with cyclic structure are believed to be beneficial to the rigidity and stability of the metal complexes, which is desirable for improving OLED device performance.

Abstract: Organometallic compounds comprising an imidazole carbene ligand having a N-containing ring fused to the imidazole ring are provided. In particular, the N-containing ring fused to the imidazole ring may contain one nitrogen atom or more than one nitrogen atom. These compounds may demonstrate high photoluminescent (PL) efficiency, Gaussian emission spectra, and/or short excited state lifetimes. These materials may be especially useful as blue phosphorescent emitters.

Abstract: A composition comprising a first compound capable of functioning as a phosphorescent emitter in an organic light emitting device at room temperature is provided. The first compound includes at least one substituent R, where each of the at least one substituent R has the formula of: - - -G1-G2, where the dashed line denotes the bond through which R is attached in the first compound; G1 is a non-aromatic cyclic or polycyclic group; G2 is selected from aryl and heteroaryl; and G1 and G2 are independently, optionally further substituted with a substituent selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. Organic light emitting devices, consumer products, and formulations containing the first compound are also provided.

Abstract: Novel heteroleptic iridium carbene complexes are provided. The complexes have lower-than expected sublimation temperatures, which is beneficial for the processing of these materials in solid state applications. Selective substitution of the ligands provides for phosphorescent compounds that are suitable for use in a variety of OLED devices. The carbene complexes can also be used as materials in a hole blocking layer and/or an electron transport layer to improve device performance.

Abstract: New metal complexes containing a substituted fused aromatic moiety is disclosed. The substituents on the fused aromatic moiety fine-tune molecular energy levels and solid-state self-assembly, conducive to improved material performance in devices useful for phosphorescent organic light emitting devices.

Abstract: Novel heteroleptic iridium carbene complexes are provided, which contain phenyl imidazole moieties. In particular, ligands containing 2,4,6-trisubstituted N-phenyl imidazole fragments have highly desirable properties that make them suitable materials for use in OLED devices.

Abstract: Novel heteroleptic iridium carbene complexes are provided. The complexes have lower-than expected sublimation temperatures, which is beneficial for the processing of these materials in solid state applications. Selective substitution of the ligands provides for phosphorescent compounds that are suitable for use in a variety of OLED devices. The carbene complexes can also be used as materials in a hole blocking layer and/or an electron transport layer to improve device performance.